Good News For Drug-eluting Stent Makers

Implications: Two new studies add to the safety data of off-label use of drug-eluting stents.

Analysis: Recently, many cardiologists have been concerned about the safety of these  stents. Some have fallen back to the older, bare-metal stents, and avoided using them off-label.

These studies should provide physicians with additional, but not complete confidence.

The fact that two similar studies were conducted, and saw similar results, adds to the credibility of the findings.